Allistair A. Abraham

Hematology | Oncology

111 Michigan Ave NW
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.

Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.

Journal: Transplantation and cellular therapy

Published: June 03, 2026

Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease.

Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 19, 2026

Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease.

Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease.

Journal: European journal of haematology

Published: March 12, 2026

G-CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution.

G-CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution.

Journal: American journal of hematology

Published: January 19, 2026

Nonmyeloablative HLA-identical sibling transplant for sickle cell disease in children: A multicenter prospective study.

Nonmyeloablative HLA-identical sibling transplant for sickle cell disease in children: A multicenter prospective study.

Journal: Blood advances

Published: January 05, 2026

Nonmyeloablative HLA-identical sibling transplant for sickle cell disease in children: a multicenter prospective study.

Nonmyeloablative HLA-identical sibling transplant for sickle cell disease in children: a multicenter prospective study.

Journal: Blood advances

Published: January 05, 2026

Abatacept today, TMA away: protecting the endothelium.

Abatacept today, TMA away: protecting the endothelium.

Journal: Blood advances

Published: September 29, 2025

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.

Journal: American journal of hematology

Published: September 25, 2025

Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy.

Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy.

Journal: Transplantation and cellular therapy

Published: March 09, 2025

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.

Journal: NEJM evidence

Published: February 25, 2025

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

Journal: Cytotherapy

Published: June 28, 2024

International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.

International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.

Journal: Cytotherapy

Published: April 25, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026